This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: Ipca Laboratories Limited, Ipac Laboratories Limited. Active years: 2005-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2008)
- Mumbai, IN (2005 - 2018)
Company Filing History:
Years Active: 2005-2018
Title: **Satish Rajanikant Soudagar: Innovator in Anti-Thrombotic Compounds**
Introduction
Satish Rajanikant Soudagar is a prominent inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents related to innovative anti-thrombotic compounds. His work aims to provide solutions for the treatment and prophylaxis of thrombo-embolism and cardiovascular diseases.
Latest Patents
Among his latest patents, Satish has developed new anti-thrombotic compounds, specifically the compound (7aS,2'S)-2-oxoclopidogrel and its pharmaceutically acceptable salts. These compounds have significant potential for treating various cardiovascular conditions. Additionally, he has patented solid forms of methyl (7aS,2'S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one) acetate, further demonstrating his innovative approach to enhancing cardiovascular treatments.
Career Highlights
Throughout his career, Satish has worked with reputable pharmaceutical companies, including Ipca Laboratories Limited and Ipac Laboratories Limited. His experience in these organizations has allowed him to develop a deep understanding of both research and practical applications in the pharmaceutical industry.
Collaborations
Satish Rajanikant Soudagar has collaborated with notable professionals in the field, including Ashok Kumar and Nalinakshya Balaram Panda. These collaborations have been instrumental in advancing his research and innovation in anti-thrombotic therapies.
Conclusion
As an inventor, Satish Rajanikant Soudagar continues to make remarkable strides in the development of anti-thrombotic compounds. His dedication to improving healthcare outcomes for patients with cardiovascular diseases positions him as a key figure in the pharmaceutical industry. With his impressive portfolio of patents and collaborations, Satish is paving the way for future innovations in this vital area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile